Associate research fellow at National Institutes for Food and Drug Control, China.
Dr. Xiaoming Zhang is an Associate Professor at the National Institutes for Food and Drug Control, Beijing, with a strong background in molecular biology and biopharmaceutical research. He holds a Ph.D. in Life Sciences from Peking University and has held research positions at both Peking University and the National University of Singapore. His work focuses on the development of innovative reporter gene assays for evaluating therapeutic protein and peptide bioactivity. With multiple first-author publications in high-impact journals and international research experience, Dr. Zhang is recognized for his contributions to translational research and regulatory science.
🎓 Academic Background:
Dr. Xiaoming Zhang began his scientific journey with a Bachelor’s degree in Life Sciences from Hebei University (2003–2007), laying a strong foundation in biological research. Driven by a deep curiosity for life at the molecular level, he pursued his Ph.D. in Life Sciences at the prestigious Peking University (2007–2012), where he delved into advanced molecular biology and genetics. His academic rigor and commitment to scientific excellence during this formative phase established the groundwork for a successful research career.
Profile:
🧪 Professional Experience:
Dr. Zhang’s professional trajectory is marked by steady progress and international exposure. He first worked as a Research Assistant at the School of Chemical Biology & Biotechnology, Peking University (2012–2013), contributing to innovative biochemical studies. In 2013, he joined the Department of Biochemistry at Yong Loo Lin School of Medicine, National University of Singapore, where he served as a Research Fellow for nearly six years. Here, he refined his expertise in translational research and therapeutic bioassays. Since March 2019, Dr. Zhang has been serving as an Associate Professor at the National Institutes for Food and Drug Control in Beijing, playing a key role in therapeutic evaluations and regulatory science.
📚 Research Contributions:
Dr. Zhang is renowned for his pioneering work in the development of reporter gene assays to evaluate the biological activities of therapeutic proteins and peptides. His research spans a broad spectrum—from PEGylated recombinant human growth hormone to glucagon-like peptide-2 analogues, addressing critical needs in drug development. Notably, his recent publications in Journal of Pharmaceutical Analysis, Molecules, and iScience highlight his innovative approaches to bioassay design and therapeutic evaluation. His co-authorship and first-author roles in multiple peer-reviewed journals underscore his direct involvement in impactful discoveries.
🏅 Recognition and Impact:
While Dr. Zhang’s scientific publications speak volumes, his true impact lies in the translation of molecular insights into therapeutic assessment tools. His work contributes significantly to drug safety and efficacy testing, ensuring that biologics are accurately evaluated before reaching patients. As an Associate Professor at a national regulatory institute, his role bridges academic innovation and public health policy, making his contributions both scientifically rigorous and socially relevant.
🚀 Future Potential:
Dr. Xiaoming Zhang’s career demonstrates an upward trajectory with great potential for further leadership in biopharmaceutical regulation and translational research. With continued contributions to therapeutic bioactivity assays, regulatory innovation, and interdisciplinary collaborations, Dr. Zhang stands out as a valuable contributor to global health sciences. He is a strong contender for prestigious recognitions such as the Best Researcher Award, and his journey is a testament to dedication, innovation, and scientific excellence.
Publications:
-
An improved reporter gene assay for evaluating the biological activity of recombinant human growth hormone
Journal of Pharmaceutical Analysis, 2025
-
Authors: Xiaoming Zhang, Heyang Li, Ying Huang, Ping Lv, Lvyin Wang, Kezheng Xu, Yi Li, Xinyue Hu, Yue Sun, Cheng-gang Liang, Jing Li
-
Development of a Mechanism of Action-Reflective Cell-Based Reporter Gene Assay for Measuring Bioactivities of Therapeutic Glucagon-like Peptide-2 Analogues
Molecules, 2025
-
A Reporter Gene Assay for Measuring the Biological Activity of PEGylated Recombinant Human Growth Hormone
Molecules, 2025
-
Authors: Shaowang Hu*, Xiaoming Zhang*, Yi Li, Jing Li, Yingwu Wang, Chenggang Liang
-
(Co-first author)
-
MLL5 regulates Rhodopsin gene expression by acting as a novel coactivator of CRX
iScience, 2022
-
Authors: Zhang XM, Zhang BW, Xiang L, Wu H, Zhou PP, Alexander SAS, Zhou P, Dai MZ, Wang X, Xiong W, Zhang Y, Jin ZB, Deng LW
-
MLL5 (KMT2E): structure, function, and clinical relevance
Cellular and Molecular Life Sciences, 2017
-
Pluripotent Stem Cell Protein Sox2 Confers Sensitivity towards LSD1 Inhibition in Cancer Cells
Cell Reports, 2013
-
Authors: Xiaoming Zhang, Fei Lu, Jing Wang, Feng Yin, Zhengshuang Xu, Dandan Qi, Yuwen Cao, Weihua Liang, Yuqing Liu, Yundong Wu, Hong Sun, Tao Ye, Hui Zhang